Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Introduction: X-linked retinoschisis (XLRS) is an inherited retinal disease (IRD) caused by pathogenic mutations in the retinoschisin gene, RS1. Affected individuals develop retinal layer separation, ...

1 Academic Unit of Medical Genetics, St Mary’s Hospital, University of Manchester, Manchester, UK 2 Centre for Molecular Medicine, Faculty of Medical and Human Sciences, University of Manchester, ...

tmd.ac.jp Aims: To investigate the morphological changes that occur during the development of an early retinal detachment (RD) from a myopic macular retinoschisis (MRS) by optical coherence tomography ...

In total, 30.8% of the eyes had a final vision ≥20/200. Conclusion: The presence of retinoschisis (retinal cyst) in Coats disease is strongly associated with retinal telangiectasia and exudation and ...

3 Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, People's Republic of China Aims Choroidal neovascularisation (CNV) in patients with X-linked retinoschisis (XLRS) has ...

To avoid disaster, the Government has limits for legal and illegal drugs, so ask your doctor if you’re unsure. But it’s not just prescription drugs that can see you banned from the steering wheel - ...

NT: Not tested; TCID: Tissue culture infectious dose. 2 Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia 3 Department of Medical ...

Emmanouil Angelakis; Esam I Azhar; Fehmida Bibi; Muhammad Yasir; Ahmed K Al-Ghamdi; Ahmad M Ashshi; Adel G Elshemi; Didier Raoult ...